Capital Structure, Investments, and Financing Activities

(38) Other financial liabilities

Accounting and measurement policies
Other financial liabilities

With the exception of liabilities from derivatives and contingent considerations recognized in the context of business combinations according to IFRS 3, other financial liabilities are initially measured at fair value and in subsequent periods at amortized cost, applying the effective interest method. The accounting and measurement policies for derivatives are presented in Note (39) Derivative financial instruments.

Other financial liabilities comprised the following:

Other financial liabilities

 

 

Dec. 31, 2025

 

Dec. 31, 2024

€ million

 

Current

 

Non-current

 

Total

 

Current1

 

Non-current1

 

Total

Miscellaneous other financial liabilities

 

976

 

85

 

1,061

 

993

 

126

 

1,118

thereof: liabilities to related parties

 

750

 

 

750

 

743

 

 

743

thereof: interest accruals

 

74

 

 

74

 

50

 

 

50

Liabilities from derivatives (operational)

 

21

 

19

 

41

 

38

 

18

 

56

Other financial liabilities

 

998

 

104

 

1,102

 

1,031

 

144

 

1,174

1

Previous-year figures have been adjusted owing to the finalization of the purchase price allocation in connection with the acquisitions of Mirus Bio LLC, USA, Unity-SC SAS, France, as well as Hub Organoids Holding B.V., Netherlands (see Note (6) Acquisitions and divestments).

The liabilities to related parties primarily consist of liabilities to E. Merck KG, Darmstadt, Germany.

Share this page: